Profile

Company Profile

Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, known as the AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures and is intended to be regulated as a medical device.

Company Info

Address:
235 Walnut Street
Suite 6
Framingham, MA 01702 US

Telephone:
855-340-2784

Email:
investors@archtherapeutics.com

Industry Classifications

Sector:
Industrials

Industry:
Conglomerates

NAICS:
Offices of Other Holding Companies (551112)

SIC:
Offices Of Holding Companies, Not Elsewhere Classified (6719)